1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > Seoul National University Hospital - Strategic SWOT Analysis Review

Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpatient, inpatient, medical examination, billing and insurance, issuance service, emergency service and home care services. SNUH through its Department of Education and Research provides educational and training services for professors, specialists, residents, students and staff; and through its SNU Biomedical Research Institute carries out clinical research activities. The hospital’s International Healthcare Center provides medical services for international patients and offers services such as primary medical care, medical examination, follow-up of chronic adult disease, visa medical examination, cancer screening, and aviation medicine consultation services, among others. It operates through its branches including Children's Hospital, Cancer Hospital, Healthcare System Gangnam Center, LA Office, Bundang Hospital, and Boramae Hospital. SNUH is headquartered in Seoul, Korea.

Seoul National University Hospital Key Recent Developments

Aug 26, 2015: OmniComm Systems Announces the Go-Live of TrialOne at Seoul National University Hospital

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Seoul National University Hospital - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Seoul National University Hospital - Key Facts 5
Seoul National University Hospital - Key Employees 6
Seoul National University Hospital - Major Products and Services 7
Seoul National University Hospital - History 8
Seoul National University Hospital - Company Statement 9
Seoul National University Hospital - Locations And Subsidiaries 10
Head Office 10
Other Locations and Subsidiaries 10
Section 2 - Company Analysis 11
Seoul National University Hospital - Business Description 11
Seoul National University Hospital - SWOT Analysis 13
SWOT Analysis - Overview 13
Seoul National University Hospital - Strengths 13
Strength - Diversified Service Offerings 13
Strength - Strong Research and Development Activities 13
Strength - Strong Operational Network 13
Seoul National University Hospital - Weaknesses 14
Weakness - Employee Issues 14
Seoul National University Hospital - Opportunities 15
Opportunity - Changing Demographics 15
Opportunity - Business Initiatives 15
Opportunity - Healthcare Market: South Korea 15
Seoul National University Hospital - Threats 16
Threat - Uncertain RandD Outcomes 16
Threat - Competitive Pressures 16
Threat - Stringent Government Regulations 16
Seoul National University Hospital - Key Competitors 17
Section 3 - Company's Lifesciences Financial Deals and Alliances 18
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 18
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 19
Seoul National University Hospital, Recent Deals Summary 20
Section 4 - Company's Recent Developments 21
Aug 26, 2015: OmniComm Systems Announces the Go-Live of TrialOne at Seoul National University Hospital 21
Section 5 - Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Seoul National University Hospital, Key Facts 5
Seoul National University Hospital, Key Employees 6
Seoul National University Hospital, Major Products and Services 7
Seoul National University Hospital, History 8
Seoul National University Hospital, Other Locations 10
Seoul National University Hospital, Subsidiaries 10
Seoul National University Hospital, Key Competitors 17
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 18
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 19
Seoul National University Hospital, Recent Deals Summary 20

List of Figures
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 18
Seoul National University Hospital, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 19

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘NT-3 ...

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global ...

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.